RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Charles Davis III

As a dedicated member of the Board of Directors for NephCure, Charles Davis lll brings invaluable expertise to guide strategic decisions and foster growth. With a passion for advancing kidney disease research and patient advocacy, Charles champions initiatives aimed at improving the lives of those affected by nephrotic syndrome. His unwavering commitment to NephCure's mission underscores his pivotal role in driving positive change within the organization and the broader kidney disease community.

Tampa, FL

Related News

NEWS

NephCure Advocacy Efforts Yield Unprecedented Support for New Era Act 

NEWS

NephCure Announces First-Ever IgA Nephropathy (IgAN) Awareness Day on September 26, 2024 

NEWS

Reykjavik Meeting Propels PARASOL Project Forward in FSGS Treatment Revolution 

NEWS

FDA Grants Fabhalta Accelerated Approval for Treatment of IgA Nephropathy in Adults

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.